Global Arterial Stents Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

This report extensively covers different segments of Global Arterial Stents Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments.

The Global Arterial Stents Market, segmented by product type, includes Drug-Eluting Stents (DES), Bare-Metal Stents (BMS), and Bioabsorbable Stents. Among these, Drug-Eluting Stents (DES) held the largest market share due to their ability to release medication over time, preventing restenosis and reducing the risk of thrombosis. The demand for DES is expected to continue growing, driven by technological advancements and the rising prevalence of cardiovascular diseases globally. Bare-Metal Stents (BMS) are also widely used, particularly in patients who may be at higher risk of complications from drug-eluting stents. Meanwhile, the emergence of bioabsorbable stents, which are gradually absorbed by the body after implantation, presents a promising avenue for future growth in the arterial stents market, offering potential benefits such as reduced inflammation and improved long-term outcomes.

Cobalt Chromium stents are among the most commonly used metallic stents due to their excellent mechanical properties, such as high tensile strength and radiopacity. The market is witnessing increased adoption of newer materials such as Platinum Chromium, which offer improved flexibility and visibility during stent placement procedures. Bioabsorbable stents made from polymers or other biocompatible materials are gaining traction, driven by their potential to minimize long-term complications associated with permanent metallic stents. The choice of stent material depends on factors such as patient characteristics, lesion morphology, and procedural considerations, contributing to the diverse landscape of the arterial stents market.

Hospitals dominate the end-user segment, accounting for the largest market share due to the high volume of arterial stent procedures performed in hospital settings, along with the availability of specialized cardiac care facilities. Cardiac centers also play a significant role in the arterial stents market, particularly those with advanced capabilities for interventional cardiology procedures and cardiac surgery. Ambulatory Surgical Centers (ASCs) are increasingly becoming important contributors to the market, offering convenient and cost-effective alternatives for certain cardiovascular procedures, including arterial stent placement, particularly in outpatient settings. The segment analysis underscores the diverse range of end-users in the arterial stents market, each playing a crucial role in driving demand and adoption of stent technologies worldwide.

Global Arterial Stents Segment Analysis

In this report, the Global Arterial Stents Market has been segmented by Product, Material , End-User and Geography.

Global Arterial Stents Market , Segmentation by Product

The Global Arterial Stents Market has been segmented by Product into Drug-Eluting Stents, Bare-Metal Stents, and Bioabsorbable Stents.

Drug-Eluting Stents (DES) remain the dominant segment, accounting for a substantial market share. These stents, coated with medication to prevent restenosis and thrombosis, offer superior outcomes compared to bare-metal stents, driving their widespread adoption in coronary interventions. The development of next-generation drug-eluting stents with improved biocompatibility and drug release kinetics further enhances their efficacy and safety profile, contributing to their continued market dominance.

Bare-Metal Stents (BMS) also maintain a significant presence in the arterial stents market, particularly in regions with cost constraints or concerns over long-term dual antiplatelet therapy. While DES offer superior clinical outcomes in terms of reduced rates of restenosis, BMS are preferred in certain patient populations, such as those at higher risk of bleeding complications or requiring shorter-term antiplatelet therapy. The emergence of bioabsorbable stents presents a promising avenue for market growth, with ongoing research focused on enhancing their mechanical properties and biodegradation kinetics. These stents, designed to gradually dissolve over time, offer potential benefits such as reduced inflammation and improved vascular healing, addressing some limitations associated with permanent metallic stents. As technological innovations and clinical evidence continue to drive advancements in arterial stent design and materials, the market for arterial stents is expected to witness sustained growth in the coming years.

Global Arterial Stents Market , Segmentation by Material

The Global Arterial Stents Market has been segmented by Material into Metallic Stents,Nickel Titanium, Stainless Steel, Cobalt Chromium, Platinum Chromium, and Other Stents.

Cobalt Chromium stents have been a dominant choice in the arterial stents market, owing to their superior mechanical properties and biocompatibility. According to recent data, Cobalt Chromium stents accounted for over 40% of the global arterial stents market share in 2021. This dominance can be attributed to factors such as their high tensile strength, excellent radial strength, and low rates of restenosis, making them suitable for a wide range of coronary artery lesions.

Platinum Chromium stents are gaining traction in the market due to their improved flexibility and visibility during stent placement procedures. Market analysis indicates that Platinum Chromium stents are witnessing rapid adoption, with a projected growth rate from 2022 to 2027. This growth is fueled by advancements in stent design and manufacturing processes, enhancing the performance and deliverability of these stents. The rising prevalence of cardiovascular diseases globally, coupled with the increasing demand for minimally invasive interventions, is driving the expansion of the arterial stents market. As a result, manufacturers are investing in research and development activities to innovate stent materials and designs, further propelling market growth and offering promising opportunities for stakeholders in the arterial stents industry.

Global Arterial Stents Market , Segmentation by End-User

The Global Arterial Stents Market has been segmented by End-User into Cardiac Centers, Hospitals, and Ambulatory Surgical Centers.

Hospitals, accounting for a substantial share of the end-user segment, continue to lead the market due to their pivotal role in providing specialized cardiac care services and conducting a high volume of arterial stent procedures. With the rising prevalence of cardiovascular diseases globally, hospitals are equipped with advanced infrastructure and skilled healthcare professionals to perform interventional cardiology procedures, including arterial stent placement. The increasing adoption of minimally invasive techniques and technological advancements in stent design and materials contribute to the growth of arterial stent procedures in hospital settings.

Cardiac centers also play a crucial role in driving demand for arterial stents, particularly those with advanced capabilities for interventional cardiology procedures. These specialized centers focus on the diagnosis, treatment, and management of various cardiovascular conditions, offering comprehensive care to patients with complex cardiac issues. As the demand for cardiac interventions continues to rise, driven by factors such as aging populations and lifestyle-related risk factors, cardiac centers are expected to witness steady growth in arterial stent procedures.Ambulatory Surgical Centers (ASCs) are emerging as important contributors to the arterial stents market, offering convenient and cost-effective alternatives for certain cardiovascular procedures. With advancements in medical technology enabling more procedures to be performed in outpatient settings, ASCs are increasingly catering to patients seeking minimally invasive treatments, including arterial stent placement, thereby expanding the accessibility of arterial stent procedures to a broader patient population.

Global Arterial Stents Market, Segmentation by Geography

In this report, the Global Arterial Stents Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Arterial Stents Market Share (%), by Geographical Region, 2023

North America holds a significant share in the arterial stents market, attributed to factors such as the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and technological advancements in medical devices. According to recent data, North America accounts for a substantial portion of the global arterial stents market, with the United States leading the region in terms of market size and revenue generation. Additionally, increasing awareness about minimally invasive treatment options and the growing adoption of advanced stent technologies contribute to the market's growth in this region.

In Europe, the arterial stents market is characterized by steady growth, driven by factors such as the rising geriatric population, increasing incidence of cardiovascular disorders, and favorable government initiatives promoting the adoption of innovative medical devices. Countries like Germany, France, and the United Kingdom are major contributors to the European arterial stents market, with significant investments in healthcare infrastructure and research and development activities.The region witnesses a growing trend towards minimally invasive procedures and personalized medicine, further propelling market growth. With ongoing technological advancements and strategic collaborations among key market players, Europe is expected to continue its prominent position in the global arterial stents market in the foreseeable future.